NO20062236L - Avendelse av organiske sammensetninger - Google Patents

Avendelse av organiske sammensetninger

Info

Publication number: NO20062236L
Authority: NO; Norway
Prior art keywords: disposal; organic compositions; ccb; benazepril; mortality
Prior art date: 2003-10-20

Application number

NO20062236A

Other languages

English (en)

Norwegian (no)

Inventor

Ken Jamerson

Malcolm Macnab

Bertram Pitt

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-20

Filing date

2006-05-18

Publication date

2006-07-19

2006-05-18 Application filed by Novartis Ag filed Critical Novartis Ag

2006-07-19 Publication of NO20062236L publication Critical patent/NO20062236L/no

Links

239000000203 mixture Substances 0.000 title 1
239000005541 ACE inhibitor Substances 0.000 abstract 1
XPCFTKFZXHTYIP-PMACEKPBSA-N Benazepril Chemical compound C([C@@H](C(=O)OCC)N[C@@H]1C(N(CC(O)=O)C2=CC=CC=C2CC1)=O)CC1=CC=CC=C1 XPCFTKFZXHTYIP-PMACEKPBSA-N 0.000 abstract 1
229940127291 Calcium channel antagonist Drugs 0.000 abstract 1
ZPBWCRDSRKPIDG-UHFFFAOYSA-N amlodipine benzenesulfonate Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl ZPBWCRDSRKPIDG-UHFFFAOYSA-N 0.000 abstract 1
229960004005 amlodipine besylate Drugs 0.000 abstract 1
229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 abstract 1
229960004530 benazepril Drugs 0.000 abstract 1
230000002526 effect on cardiovascular system Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)

NO20062236A 2003-10-20 2006-05-18 Avendelse av organiske sammensetninger NO20062236L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US51263403P	2003-10-20	2003-10-20
PCT/EP2004/011824 WO2005037278A2 (en)	2003-10-20	2004-10-19	Tbenazpril and amlodipine for reducing cardiovascular morbidity

Publications (1)

Publication Number	Publication Date
NO20062236L true NO20062236L (no)	2006-07-19

Family

ID=34465367

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20062236A NO20062236L (no)	2003-10-20	2006-05-18	Avendelse av organiske sammensetninger

Country Status (19)

Country	Link
US (2)	US20060233876A1 (pt)
EP (1)	EP1776115A2 (pt)
JP (1)	JP2007511473A (pt)
KR (1)	KR20060120126A (pt)
CN (1)	CN101137367A (pt)
AU (1)	AU2004281541B2 (pt)
BR (1)	BRPI0415530A (pt)
CA (1)	CA2542757A1 (pt)
IL (1)	IL174927A0 (pt)
IS (1)	IS8470A (pt)
MA (1)	MA28108A1 (pt)
MX (1)	MXPA06004369A (pt)
NO (1)	NO20062236L (pt)
RU (1)	RU2006117198A (pt)
SG (1)	SG147456A1 (pt)
TN (1)	TNSN06111A1 (pt)
TW (1)	TW200524591A (pt)
WO (1)	WO2005037278A2 (pt)
ZA (1)	ZA200602994B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10127130B2 (en) *	2005-03-18	2018-11-13	Salesforce.Com	Identifying contributors that explain differences between a data set and a subset of the data set
US9940405B2 (en)	2011-04-05	2018-04-10	Beyondcore Holdings, Llc	Automatically optimizing business process platforms
US8158146B2 (en)	2005-09-28	2012-04-17	Teva Pharmaceutical Industries Ltd.	Stable combinations of amlodipine besylate and benazepril hydrochloride
CN102008708B (zh) *	2009-07-14	2013-02-20	邬林祥	一种治疗高血压含雷米普利的复方制剂
WO2011161223A2 (en)	2010-06-23	2011-12-29	Krka, Tovarna Zdravil, D.D., Novo Mesto	Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
US10802687B2 (en)	2011-12-04	2020-10-13	Salesforce.Com, Inc.	Displaying differences between different data sets of a process
US10796232B2 (en)	2011-12-04	2020-10-06	Salesforce.Com, Inc.	Explaining differences between predicted outcomes and actual outcomes of a process
CN102440993B (zh) *	2011-12-08	2013-04-17	扬子江药业集团广州海瑞药业有限公司	一种氨氯地平和贝那普利的药物组合物
RU2014129508A (ru) *	2011-12-21	2016-02-10	Новартис Тиргезундхайт АГ	Новая комбинация
CN102688245A (zh) *	2012-06-11	2012-09-26	北京阜康仁生物制药科技有限公司	一种稳定的氨氯地平与贝那普利药用组合物及其制备方法
JP2014219945A (ja) *	2013-05-10	2014-11-20	富士通株式会社	治験情報出力装置、治験情報出力方法および治験情報出力プログラム
HRP20230267T1 (hr)	2017-01-25	2023-06-09	The George Institute for Global Health	Pripravci za liječenje hipertenzije
US12521380B2 (en)	2017-01-25	2026-01-13	The George Institute for Global Health	Compositions for the treatment of hypertension
US20200111575A1 (en) *	2018-10-04	2020-04-09	Babylon Partners Limited	Producing a multidimensional space data structure to perform survival analysis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6162802A (en) *	1992-03-10	2000-12-19	Papa; Joseph	Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
EP0795327A1 (en) *	1996-03-13	1997-09-17	Pfizer Inc.	Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin
AU2001225816B2 (en) *	2000-12-18	2005-10-13	Novartis Ag	Therapeutic combination of amlodipine and benazepril
TW200306799A (en) *	2002-05-17	2003-12-01	Novartis Ag	Combination of organic compounds

2004
- 2004-10-19 KR KR1020067009736A patent/KR20060120126A/ko not_active Withdrawn
- 2004-10-19 TW TW093131725A patent/TW200524591A/zh unknown
- 2004-10-19 SG SG200807826-3A patent/SG147456A1/en unknown
- 2004-10-19 CA CA002542757A patent/CA2542757A1/en not_active Abandoned
- 2004-10-19 MX MXPA06004369A patent/MXPA06004369A/es not_active Application Discontinuation
- 2004-10-19 CN CNA2004800381794A patent/CN101137367A/zh active Pending
- 2004-10-19 EP EP04817199A patent/EP1776115A2/en not_active Ceased
- 2004-10-19 BR BRPI0415530-0A patent/BRPI0415530A/pt not_active IP Right Cessation
- 2004-10-19 JP JP2006536030A patent/JP2007511473A/ja not_active Withdrawn
- 2004-10-19 WO PCT/EP2004/011824 patent/WO2005037278A2/en not_active Ceased
- 2004-10-19 AU AU2004281541A patent/AU2004281541B2/en not_active Ceased
- 2004-10-19 RU RU2006117198/15A patent/RU2006117198A/ru unknown
- 2004-10-20 US US10/969,700 patent/US20060233876A1/en not_active Abandoned
2006
- 2006-04-11 IL IL174927A patent/IL174927A0/en unknown
- 2006-04-11 ZA ZA200602994A patent/ZA200602994B/en unknown
- 2006-04-19 TN TNP2006000111A patent/TNSN06111A1/en unknown
- 2006-04-25 MA MA28962A patent/MA28108A1/fr unknown
- 2006-05-16 IS IS8470A patent/IS8470A/is unknown
- 2006-05-18 NO NO20062236A patent/NO20062236L/no not_active Application Discontinuation
2007
- 2007-11-29 US US11/867,891 patent/US20080242659A1/en not_active Abandoned

Also Published As

Publication number	Publication date
MA28108A1 (fr)	2006-08-01
CA2542757A1 (en)	2005-04-28
EP1776115A2 (en)	2007-04-25
US20080242659A1 (en)	2008-10-02
IL174927A0 (en)	2008-04-13
RU2006117198A (ru)	2007-12-10
US20060233876A1 (en)	2006-10-19
TW200524591A (en)	2005-08-01
CN101137367A (zh)	2008-03-05
ZA200602994B (en)	2008-03-26
KR20060120126A (ko)	2006-11-24
AU2004281541A1 (en)	2005-04-28
BRPI0415530A (pt)	2006-12-26
IS8470A (is)	2006-05-16
WO2005037278A2 (en)	2005-04-28
JP2007511473A (ja)	2007-05-10
SG147456A1 (en)	2008-11-28
WO2005037278A3 (en)	2007-05-10
AU2004281541B2 (en)	2008-05-01
MXPA06004369A (es)	2006-06-14
TNSN06111A1 (en)	2007-11-15

Legal Events

Date	Code	Title	Description
2010-05-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
CY1106044T1 (el)	2011-04-06	Συνεργατικος αναλγητικος συνδυασμος οπιωδους αναλγητικου και αναστολεα της κυκλοοξυγενασης -2
SG147456A1 (en)	2008-11-28	Use of organic compounds
ATE280171T1 (de)	2004-11-15	Stickstoffhaltige heterobicyclen als faktor-xa- hemmer
NO20041709L (no)	2004-04-23	N-substituerte pyrrolidinderivater som dipeptidyl peptidase IV inhibitorer
ATE339419T1 (de)	2006-10-15	Pyrazolenthaltende zusammensetzungen und ihre verwendung als gsk-3 inhibitoren
IL165101A0 (en)	2005-12-18	Combination of a dpp IV inhibitor and a cardiovas cular compounds
NO20034964D0 (no)	2003-11-07	Sementsammensetning egnet for olje- og gassbrönner
NO20012229D0 (no)	2001-05-04	Kombinasjonsbehandling med angiotensin-konverterende enzyminhibitor og aldosteron-antagonist for reduksjon avmorbiditet og mortalitet ved kardiovaskul¶re sykdommer
WO2001076574A3 (en)	2002-04-25	Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists
AR008782A1 (es)	2000-02-23	Una composicion farmaceutica antitrombotica y antiaterogena, y sus usos
AU2003232791A1 (en)	2003-12-02	Combination of an ace inhibitor, a calcium channel blocker and a diuretic
TW200508226A (en)	2005-03-01	Compositions, combinations, and methods for treating cardiovascular conditions and other associated conditions
IS6111A (is)	2001-10-19	Lyfjablanda sem felur í sér þrombínhemil með lágan mólmassa og forlyf hans
IL153937A0 (en)	2003-07-31	Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
TR200000419T2 (tr)	2000-09-21	Feksofenadin ve türevlerinin biyo elde edilebilirliklerinin arttırılması yöntemi.
IS6507A (is)	2002-08-16	Píperidín- og píperasín útskipt N-hýdroxýformamíðsem málmpróteinasatálmar
GR20010100602A (el)	2002-10-09	Ασπαρτικο παραγωγο της αμλοδιπινης.
ATE287416T1 (de)	2005-02-15	Thrombin inhibitoren
AU2003217444A1 (en)	2003-10-13	A compound as cholinesterase inhibitor and its isolation from fungus sporotrichum species
MXPA03005882A (es)	2005-04-19	Derivado amida de amlodipina.
DE60031171D1 (de)	2006-11-16	Ace inhibitor-vasopressin antagonist kombinationen
NO20014191D0 (no)	2001-08-29	Lås for höy belastning og stor boring
UY26893A1 (es)	2002-03-22	Combinación farmacéutica de antagonistas de la angiotensina ii e inhibidores de la enzima de conversión de la angiotensina i
NO20015128D0 (no)	2001-10-19	Synergistiske virkninger av amlodipin og atorvastatin
ATE227571T1 (de)	2002-11-15	Thrombin inhibitoren